News

Filter

101 to 110 of 97577 results

Supreme Court reverses Federal Circuit Court judgment on '808 patent in Teva's Copaxone

Supreme Court reverses Federal Circuit Court judgment on '808 patent in Teva's Copaxone

21-01-2015

The US Supreme Court has reversed the Federal Circuit Court’s judgment on Israel-based Teva Pharmaceutical…

CopaxoneLegalNeurologicalPharmaceuticalTevaUSA

Naming conventions for biosimilars in Australia

Naming conventions for biosimilars in Australia

21-01-2015

Following recent international developments in the area of biosimilar naming, Australian regulator the…

AustraliaBiosimilarsBiotechnologyRegulationTherapeutic Goods Administration

Life sciences companies unprepared for whistleblower lawsuits, survey finds

Life sciences companies unprepared for whistleblower lawsuits, survey finds

21-01-2015

Although health care and life sciences companies are aware that they could be hit with federal “whistleblower”…

DissentFoley Hoag LLPLegalPharmaceuticalUSA

Report: Orphan drug prices facing increased scrutiny

Report: Orphan drug prices facing increased scrutiny

21-01-2015

With the US Food and Drug Administration approving an all-time record number of orphan drugs during 2014,…

PharmaceuticalPricingRare diseases

Salix reportedly pursing acquisition, pushed by shareholders

Salix reportedly pursing acquisition, pushed by shareholders

21-01-2015

USA-based Salix Pharmaceuticals is reportedly pursuing acquisition by a large drugmaker.

Mergers & AcquisitionsPharmaceuticalReutersSalix PharmaceuticalsUSA

Holger Zimmermann replaces founding chief executive of AiCuris

Holger Zimmermann replaces founding chief executive of AiCuris

21-01-2015

AiCuris, a company formed by experts from Bayer's virology and bacteriology research divisions, is to…

AiCurisAntibiotics and Infectious diseasesBiotechnologyBoardroomGermany

US FTC approves final order preserving in nicotine patches market competition

US FTC approves final order preserving in nicotine patches market competition

21-01-2015

Following a public comment period, the USA’s Federal Trade Commission has approved a final order settling…

GlaxoSmithKlineHabitrolMergers & AcquisitionsNeurologicalNovartisPharmaceuticalRegulationUSA

New phase of MAb biosimilars opportunities in Japan

New phase of MAb biosimilars opportunities in Japan

21-01-2015

The launch of Remicade (infliximab, from Johnson & Johnson) biosimilar in December 2014 in the Japan…

BiosimilarserythropoietinGenericsJapanMarkets & MarketingRegulationRemicade

101 to 110 of 97577 results

Back to top